The cardiarespiratory and analgesic effects of romifidine or xylazine combined with ketamine was investigated in dogs. Dogs were premedicated with 1.0 mg/kg of methotrimeprazine IV, followed by 0.1 mg/kg of romifidine (n = 8) or 1.0 mg/kg of xylazine (n = 8) and 15 mg/kg of ketamine 1M, using a double blind randomised designo Dogs of both groups developed hypothermia, bradycardia, slight hypotension and reduction in respiratory rate and minute volume. There were rninimal changes in end tidal CO 2 and 02 saturation. There were no differences either in time ar between the groups in pH, Pa0 2 , and blood biochemistry. The reflexes to pain were reduced until 30-45 minutes of anaesthesia in both groups. Twelve bitches were divided in two groups as above and underwent ovariohysterectomy. Recovery was longer after romifidine/ketamine when compared to xylazine/ketamine in both snídies. Although these anaesthetic protocols produced minimal cardiorespiratory changes, the quality of anaesthesia was not ideal for ovariohysterectomy.
INTRODUCTION
Q ne of the most popular injectable anaesthesia used for small animais is the combination of (X-2 adrenoceptor agonists and ketaminev'. Alpha-2 adrenoceptor agonists produce sedation, analgesia and muscle relaxation-ó". Other effects of (X-2 adrenoceptor agonists include bradycardia, arhythmia, atrioventricular block, transitory hypertension, followed by hypotension, increase of central venous pressure, reduction of systolic volume and cardiac output, increase of vascular resistance and respiratory depression, produced by reduction of respiratory rate and minute volume'>.
Romifidine is a potent and selective (X-2adrenoceptor agonist that produces similar cardiorespiratory effects to other drugs of this group. In horses, romifidine produced a longer sedation than xylazine'. England et al. ' compared the effect of several doses of romifidine in dogs. No difference in sedation was observed among these doses, but higher doses produced a more consistent effect.
Ketarnine is a dissociative anaesthetic widely used in combination with several drugs in dogs. Ketarnine produces increased motor activity, hyperreflexia and sympathetic activation", effects which are counterbalanced when this drug is combined with (X-2adrenoceptor agonists":". However the use of (X-2 adrenoceptor agonists even combined with ketamine may produce emesis, increased secretions, arhythmia and atrioventricular block'. Atropine may be used to prevent the xylazine-induced salivation, bradycardia and arhythmia, but intense hypertension produced by the combination of these two drugs is an undesirable effect". Phenotyazines are also widely used for premedication of dogs. These drugs reduce secretion and have an antiemetic and antiarrhythmic effects. Methotrimeprazine is a typical phenotyazine, with the advantage of producing a similar analgesic effect of morphine'.
The aim of this paper was to study the analgesic and cardiorespiratory effects of dogs premedicated with methotrimeprazine and anaesthetised with romifidine or xylazine, combined with ketarnine.
MATERIAL AND METHOD
This paper was divided in two studies. The first study was carried out without surgery. The cardiopulmonary effects of the combination of methotrimeprazine, xylazine and ketamine or methotrimeprazine, romifidine and ketamine were investigated. The second study evaluated the efficacy of these combinations in order to perform ovariohysterectomy in bitches.
Study 1 -Anaesthesia
Sixteen mongrel adult dogs weighing 10.2 ± 0.7 kg and from both sexes were used in a double blind randomised study. They were starved of food for 12 hours and water was withheld 2 hours before the beginning of the experiment. Dogs were premedicated with 1 mg/kg of methotrimeprazine a intravenously. A 20 gauge catheter b was introduced in the metatarsal artery for collection of arterial blood samples and measurement of arterial blood gases. Fifieen minutes later dogs received an injection of 1 mglkg of xylazine-combined with 15 mglkg of ketamine:' (n = 8) or 0.1 mglkg of romifidine ' combined with 15 mglkg of ketarrtine (n = 8) intramuscularly. Rectal temperature f, heart rate and electrocardiogram g, indirect mean arterial blood pressure measured in the radial artery h, respiratory rate, tidal and minute volume i were measured before premedication, 15 minutes after premedication, every 15 minutes after romifidine/ketamine administration for 120 minutes. Expired CO o and haemoglobin 0 0 saturation ' and arterial blood gas analysis, glucose and electrolytes 1 were measured for 90 minutes only. Analgesia was investigated for 120 minutes, using a forceps elamped at the skin of the abdominal region elose to the umbilicus, anal sphincter and interdigital space. Musele relaxation was also investigated for 120 minutes. The nociceptive response was scored as "O" normal response, "1" reduced response and "2" no response. All measurements were performed only until 90 minutes afier xylazine/ketamine.
Quality of recovery, onset of effect (from 0.-2 agonists/ ketamine administration until no response to elamping at the abdominal region), duration of anaesthesia (time to reduced response to c1amping at the abdominal region, when nociceptive response was scored at least "1"), time to the first movement of the head, time to assume stemal and standing position were also measured.
Study 2 -Surgery
Twelve bitches from several breeds, ranging from 6 to 120 (40 ± 10) months and weighing between 4 and 25 (10 ± 2) kg underwent ovariohysterectomy using the same protocol as previously described: methotrirneprazine/xylazine/ketarrtine "Neozine, Rhodia, Brazil. 
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(n = 6) and methotrimeprazine/romifidine/ketamine (n = 6). Quality of recovery, onset of effect, duration of surgery and anaesthesia, time to assume stemal and standing position and response to surgical stimulus were measured.
Statistical analysis
Statistical analysis was performed using an Apple Macintosh Statview software!", Analysis of variance (ANOVA) for repeated measures were used in each group for parametric variables to assess changes from control with time, followed by Dunnett's test when a significant difference was indicated'. One way ANOVA was used to compare the groups at each time point followed by Fisher's Paired Least Square Difference test when appropriate. Degree of analgesia was assessed using Friedman test in each group to assess changes from control with time and Mann Whitney test, to compare the groups at each time point. Differences were considered significant when p < 0.05. The tables and graphs are expressed in means ± standard error of means.
Study 1
Time to onset of effect was 6 ± 1 minutes in both groups, duration of anaesthesia was 52 ± 6 minutes in dogs treated with methotrimeprazine/xylazine/ketamine and 60 ± 14 minutes in dogs treated with methotrimeprazine/ romifidine/ketamine. Time to standing position was 95 ± 6 minutes in dogs treated with methotrimeprazine/xylazine/ ketamine and 132 ± 17 minutes in dogs treated with methotrimeprazine/romifidine/ketamine (Tab. 1).
Methotrimeprazine/xylazinelketamine
The anal reflex was reduced until 30 minutes and the cutaneous and interdigital reflexes until 45 minutes afier administration of xylazine/ketamine (Fig. 1 •.. haemoglobin 02 saturation increased at 75 and 90 minutes and blood potassium concentration decreased at 15 and 90 minutes (Tab. 3 and 4). There was no difference in pH, PaC0 2 , expired CO 2 , osmolality and blood bicarbonate, sodium, calcium and glucose concentrations (Tab. 3 and 4).
Methotrimeprazine/romifidine/ketamine
The anal, cutaneous and interdigital reflexes were reduced until 30 minutes after administration of romifidine/ ketamine (Fig. 2) .
Temperature and heart rate decreased from 30 and from 75 minutes respectively after administration of romifidine/ ketamine until120 minutes (Tab. 3). Hypotension was observed only at 120 minutes and respiratory rate reduced from 15 to 30 and from 75 to 120 minutes after administration of romifidine/ketarnine (Tab. 3 and 4). Minute volume decreased from 15 to 120 minutes after the administration of romifidine/ ketamine (Tab.
One out of eight dogs showed atrioventricular block from 25 minutes and two from 45 minutes after administration of romifidine/ketarnine.
Comparison between groups
Sinusal arhythmia was observed in both groups. Expired CO 2 was higher at 45 and 60 minutes in the dogs treated with romifidine/ketarnine. Haemoglobin 02 saturation was lower at 90 minutes in the dogs treated with romifidine/ ketamine.
Myoc1onia, shivering and musc1e spasm occurred during anaesthesia in 8 out of 8 animais treated with romifidine/ketamine and 5 out of 8 animais treated with xylazine/ketamine .
Study 2
Time to onset of effect was 5 ± 1 and 3 ± ] minutes in dogs treated with methotrimeprazine/xylazine/ketamine and methotrimeprazinelromifidi ne/ketamine res pecti vely. Duration of anaesthesia was 59 ± 5 minutes in dogs treated with methotrimeprazine/xylazine/ketamine and 64 ± 6 minutes in dogs treated with methotrimeprazine/romifidine/ ketarnine. Time to standing position was 162 ± 30 in dogs treated with methotrimeprazine/xylazine/ketarnine and 222 ± 26 in dogs treated with methotrimeprazine/romifidine/ ketarnine (Tab. 2). Time to assume stemal and standing position was longer in this study when compared with the same anaesthetic protocol in study 1.
Intense bleeding and tension at the ovarian pedic1e was observed in three dogs treated with xylazine/ketamine. Two of these dogs needed local anaesthesia at the ovarian pedicle, followed in one of them by more 0.5 mg/kg ofxy lazine and 7.5 mg/kg of ketamine at 30 minutes during anaesthesia.
One dog from the romifidine/ketarnine group showed muscle hypertonia, movement of the head, neck and lirnbs at 35 minutes during anaesthesia and received another dose of 0.05 mg/kg of romifidine and 7.5 mg/kg ofketamine. No other reaction was observed thereafter. This animal did not show a good abdominal muscle relaxation. Bleeding and tension of the ovarian pedicle was observed in this animal and in other two dogs from this group. Table 1 Mean and Standard Error Mean (minutes) of onset of action, duration of anaesthesia, time to the first movement of the head and time to assume sternal and standing position of dogs anaesthetised with methotrimeprazine/xylazine/ ketamine and methotrimeprazine/ romifidinelketamine. There was no significant difference between the groups -Botucatu -SP, February to May 1996. Table 3 Mean and Standard Error Mean of temperature eC), heart rate (beats per minute), mean arterial blood pressure -MABP (mmHg), blood bicarbonate concentration (mEq/l), osmolality (mOsm), blood sodium (mmol/l), potassiurn (mmol/I), calcium (mg/dl) and glucose (mg/dI) concentrations in dogs anaesthetised with methotrimeprazine, xylazine and ketarnine -MXK (n = 8) and methotrimeprazine, romifidine 282±1  284±1  286±1  286±2  286±2  286±2  284±4  MRK  281±3  283±2  283±3  286±1  286±1  285±3  286±3  MXK  141±1  145±1  145±1  146±1  145±1  145±1  144±1  MRK  143±2  144±1  144±1  145±1  145±1  144±1  144±1  MXK 
DISCUSSION
Like in horses, recovery from anaesthesia was longer in dogs treated with romifidine/lcetamine when compared to xylazine/ketamine in both anaesthetic and surgical groups', Although not significant, the duration of anaesthesia was also slightly longer after romifidine/lcetamine compared with xylazine/lcetamine. Romifidine combined with ketarnine also prolonged the time of recumbence when compared to the use of romifidine alone'. It is important to mention that recovery was longer in the surgi cal cases, showing that trauma inflicted by surgery may prolong recovery. Although recovery was longer after romifidine/lcetamine, the longer duration of anaesthesia might be a potential advantage of 96 romifidine, which should be considered.
The occurrence of myoclonia, shivering and muscle spasm is a common fmding when ketamine is used 12 and apparently xylazine produced a better muscle relaxation than romifidine. This was a similar response than that observed in horses, where romifidine produced less ataxia than xylazine'.
Hypotherrnia is a common finding during anaesthesia and the causes have been discussed elsewhere-".
Reduction of the heart rate, atrioventricular block and hypotension are usually observed after the use of a-Z adrenoceptor agonists". The concomitant use of ketamine probably delayed the arterial hypotension, which was observed only at the end of anaesthesia':". The use of methotrimeprazine probably also abolished the incidence of atrioventricular block in dogs treated with xylazine/ketamine and minimised this fmding in those dogs treated with romifidine/ketamine'. Although respiratory rate and minute volume decreased in both groups, these changes did not produce respiratory acidosis as reported in a previous study, when xylazine/ketamine was used in dogs'. The differences in Pa0 2 , haemoglobin 02 saturation and blood potassium concentration in time in the two groups and the differences in expired CO 2 between the groups were minimal and did not have biological importance, as the values were within the normal range for the canine species.
Both anaesthetic techniques produced stable cardiorespiratory function and can be considered safe when this aspect is considered. Otherwise, quality of surgical anaesthesia was not ideal, as some dogs showed increased muscular tonus and also needed additional doses of the combination and even local anaesthesia at the ovarian pedicle.
